Henry W Buck1, Kathy J Guth. 1. Department of Gynecology, Watkins Memorial Student Health Center, The University of Kansas, Lawrence, KS 66045-7559, USA. hbuck@ku.edu
Abstract
OBJECTIVE: Treatment of human papillomavirus (HPV)-associated vaginal lesions (vaginal intraepithelial neoplasia [VAIN]) can be expensive, tedious, and morbidity inducing. Imiquimod 5% cream, a safe and effective treatment of external genital warts, enhances the immune response to HPV infection. MATERIALS AND METHODS: Imiquimod 5% cream was used to treat 56 young women with VAIN. One sachet of cream (0.25 g) was placed in the vagina with an applicator once weekly for 3 weeks (except for the first four patients, who were treated twice weekly). RESULTS: Thirty-six of the 42 patients (86%) available for follow-up were clear of VAIN lesions (as assessed by colposcopy) 1 week or later after the last dose of treatment. The remaining six patients cleared after a total of two (five patients) and three (one patient) treatment cycles. Vulvar or vestibular excoriation was reported in only 2 of 56 patients. No patients had vaginal ulceration. CONCLUSIONS: A very low dosing regimen of imiquimod 5% cream appears to be an effective and well-tolerated treatment for VAIN (primarily low grade.).
OBJECTIVE: Treatment of human papillomavirus (HPV)-associated vaginal lesions (vaginal intraepithelial neoplasia [VAIN]) can be expensive, tedious, and morbidity inducing. Imiquimod 5% cream, a safe and effective treatment of external genital warts, enhances the immune response to HPV infection. MATERIALS AND METHODS:Imiquimod 5% cream was used to treat 56 young women with VAIN. One sachet of cream (0.25 g) was placed in the vagina with an applicator once weekly for 3 weeks (except for the first four patients, who were treated twice weekly). RESULTS: Thirty-six of the 42 patients (86%) available for follow-up were clear of VAIN lesions (as assessed by colposcopy) 1 week or later after the last dose of treatment. The remaining six patients cleared after a total of two (five patients) and three (one patient) treatment cycles. Vulvar or vestibular excoriation was reported in only 2 of 56 patients. No patients had vaginal ulceration. CONCLUSIONS: A very low dosing regimen of imiquimod 5% cream appears to be an effective and well-tolerated treatment for VAIN (primarily low grade.).
Authors: Jeremy S Blum; Caroline E Weller; Carmen J Booth; Imran A Babar; Xianping Liang; Frank J Slack; W Mark Saltzman Journal: Drug Deliv Transl Res Date: 2011-10-01 Impact factor: 4.617
Authors: Bruno O Fonseca; Júlio C Possati-Resende; Mila P Salcedo; Kathleen M Schmeler; Guilherme S Accorsi; José H T G Fregnani; Marcio Antoniazzi; Naitielle P Pantano; Iara V V Santana; Graziela M Matsushita; Ricardo Dos Reis Journal: Obstet Gynecol Date: 2021-06-01 Impact factor: 7.661
Authors: Osmarie Martínez; Eric Miranda; Maite Ramírez; Saritza Santos; Carlos Rivera; Luis Vázquez; Tomás Sánchez; Raymond L Tremblay; Eddy Ríos-Olivares; Miguel Otero Journal: PLoS One Date: 2015-04-13 Impact factor: 3.240